Protocol of investigation into reporting quality of RCT abstracts on COVID-19 pursuant to CONSORT (CoCo study)-a review

被引:0
|
作者
Tulka, Sabrina [1 ]
Baulig, Christine [1 ]
Knippschild, Stephanie [1 ]
机构
[1] Witten Herdecke Univ, Fac Hlth, Chair Med Biometry & Epidemiol IMBE, Alfred Herrhausen Str 50, D-58448 Witten, Germany
关键词
COVID-19; CONSORT; Reporting quality; RCT; Transparency; Coronavirus; SARS-CoV-2;
D O I
10.1186/s13063-021-05937-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background In 2020, the COVID-19 pandemic developed into a global crisis, the enormity and urgency of which accelerated research activities in the field. At the same time, manuscripts describing these research projects underwent fast-track peer review procedures and were published in freely accessible formats. Although full texts about COVID-19 are currently available for free, abstracts continue to play a key role since they provide essential information and possibly a decision basis for therapies. Abstracts are particularly important in case the full texts are not free, not all reports have been published in English and in emergency situations when there is less time for comprehensive analysis of all full texts. It is therefore necessary to ensure that abstracts-as publications in miniature format-contain comprehensive and transparent information. The CONSORT statement for abstracts (CONSORT-A) offers guidelines to authors how to include all necessary information in an abstract. Prior to the COVID-19 pandemic, the quality of reporting in medical research had already been the object of debate and criticism. The current crisis makes comprehensive documentation all the more important. Abstracts of COVID-19 RCTs should therefore report the criteria listed in the CONSORT-A statement fully and verifiably. The objective of this study is to check the completeness of abstracts of all COVID-19 RTCs published to date. Methods Based on a literature search in PubMed, Embase and the Cochrane Library, all publications up to 29 October 2020 are identified and examined in terms of the subject matter (reported results from COVID-19 studies) and their study design (RTC). Subsequently, suitable publications are examined for completeness and quality of abstracts. The CONSORT checklist for RTC abstracts serves as a basis in this procedure. The primary endpoint of the study is the percentage of correctly implemented items of the CONSORT statement for abstracts. The frequency of correct reporting of each individual item is checked in a second step. Discussion The study is expected to contribute to evaluating the reporting quality on COVID-19 studies, and specifically the completeness of abstracts of RTCs. It may thus support the assessment of current research into COVID-19.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] A review of current effective COVID-19 testing methods and quality control
    Cheng, Lijia
    Lan, Liang
    Ramalingam, Murugan
    He, Jianrong
    Yang, Yimin
    Gao, Min
    Shi, Zheng
    ARCHIVES OF MICROBIOLOGY, 2023, 205 (06)
  • [22] Quality of systematic reviews of COVID-19 in people with diabetes: A systematic review
    Santos-Marques, Jaciane
    de Oliveira-Meneses, Marilyse
    Tavares-Gomes, Aline
    Rangel-Andrade, Elaine Maria Leite
    Martinez-Riera, Jose Ramon
    Lopes e Silva-Junior, Fernando
    ENFERMERIA CLINICA, 2022, 32 (06): : 367 - 375
  • [23] COVID-19 meta-analyses: a scoping review and quality assessment
    Pires, Gabriel Natan
    Bezerra, Andreia Gomes
    de Oliveira, Thaina Baenninger
    Chen, Samuel Fen, I
    Apostolakis Malfatti, Victor Davis
    Ferreira de Mello, Victoria Feiner
    Niyama, Alyne
    Pinto, Vitor Luiz Selva
    Andersen, Monica Levy
    Tufik, Sergio
    EINSTEIN-SAO PAULO, 2021, 19 : eAO6002
  • [24] The effect of acupuncture on the quality of life of patients recovering from COVID-19 A systematic review protocol
    Wen, Dengpeng
    Wu, Liu
    Dong, Yuting
    Huang, Ju
    Ren, Kuiyu
    Jiang, Jianzhen
    Dai, Shunxin
    Zhao, Wei
    Xu, Xinwei
    Peng, Dezhong
    MEDICINE, 2020, 99 (30) : E20780
  • [25] Corporate governance and financial reporting quality during the COVID-19 pandemic
    Hsu, Yu-Lin
    Yang, Ya-Chih
    FINANCE RESEARCH LETTERS, 2022, 47
  • [26] Reporting and design of randomized controlled trials for COVID-19: A systematic review
    Dillman, Alison
    Park, Jay J. H.
    Zoratti, Michael J.
    Zannat, Noor-E
    Lee, Zelyn
    Dron, Louis
    Hsu, Grace
    Smith, Gerald
    Khakabimamaghani, Sahand
    Harari, Ofir
    Thorlund, Kristian
    Mills, Edward J.
    CONTEMPORARY CLINICAL TRIALS, 2021, 101
  • [27] Interventions to mitigate COVID-19 misinformation: protocol for a scoping review
    Navin Kumar
    Nathan Walter
    Kate Nyhan
    Kaveh Khoshnood
    Joseph D. Tucker
    Chris T. Bauch
    Qinglan Ding
    S. Mo Jones-Jang
    Munmun De Choudhury
    Jason L. Schwartz
    Orestis Papakyriakopoulos
    Laura Forastiere
    Systematic Reviews, 11
  • [28] Pulmonary rehabilitation for COVID-19: A living systematic review protocol
    Pardo, Stefanie Arce
    Lai, Shuheng
    Ortiz-Munoz, Luis
    Bravo-Jeria, Rocio
    Verdugo-Paiva, Francisca
    Rada, Gabriel
    MEDWAVE, 2021, 21 (06):
  • [29] Bowel ischaemia in COVID-19 infection: a scoping review protocol
    Zhao, Yi
    Teh, Jhia Jiat
    Kung, Victor
    Mallappa, Sreelakshmi
    BMJ OPEN, 2022, 12 (09):
  • [30] A Systematic Review of the Sex and Gender Reporting in COVID-19 Clinical Trials
    Heidari, Shirin
    Palmer-Ross, Alice
    Goodman, Tracey
    VACCINES, 2021, 9 (11)